IP Verse

University Of Washington competitive analysis

Latest publications and patents of University Of Washington New

Explore the latest publications and patents granted to University Of Washington, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of University Of Washington

EP2838548
Jul 19, 2023Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses ThereofGranted And Under Opposition
EP2828218
Apr 7, 2021Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus SequencingGranted And Under Opposition
EP2699593
Nov 4, 2020Beta-2 Microglobulin-Deficient CellsPatent Maintained As Amended
EP2704737
Jan 10, 2018Therapeutic Nuclease Compositions And MethodsNo Opposition Filed Within Time Limit

Latest patents of University Of Washington opposed by its competitors

Explore University Of Washington's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2838548
Jul 19, 2023Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses Thereof2
EP2828218
Apr 7, 2021Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus Sequencing3
EP2699593
Nov 4, 2020Beta-2 Microglobulin-Deficient Cells1

Latest PTAB cases involving University Of Washington

Discover the latest PTAB cases involving University Of Washington, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 30, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving University Of Washington

IPR2022-01388Aug 10, 2022GUARDANT HEALTHUNIVERSITY OF WASHINGTONInstitution Denied
IPR2022-01159Jul 12, 2022GUARDANT HEALTHUNIVERSITY OF WASHINGTONInstitution Denied
IPR2022-01158Jul 12, 2022GUARDANT HEALTHUNIVERSITY OF WASHINGTONFinal Written Decision
IPR2022-00935May 6, 2022GUARDANT HEALTHUNIVERSITY OF WASHINGTONInstitution Denied
IPR2022-00817Apr 8, 2022GUARDANT HEALTHUNIVERSITY OF WASHINGTONFinal Written Decision - Appealed
IPR2022-00816Apr 8, 2022GUARDANT HEALTHUNIVERSITY OF WASHINGTONInstitution Denied
IPR2022-00450Jan 31, 2022GUARDANT HEALTHUNIVERSITY OF WASHINGTONInstitution Denied
IPR2022-00449Jan 31, 2022GUARDANT HEALTHUNIVERSITY OF WASHINGTONInstitution Denied
IPR2015-00057Oct 13, 2014OXFORD NANOPOREUNIVERSITY OF WASHINGTONFinal Written Decision
IPR2014-00513Mar 18, 2014OXFORD NANOPOREUNIVERSITY OF WASHINGTONFinal Written Decision

Peer Comparison New

IP litigation analysis comparing University Of Washington with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION - 6 - - Non-Active
JAMES POOLE151 - - - Highly Aggressive
LEWIS SILKIN2 - - - Highly Aggressive
MARGARET DIXON56 - - - Highly Aggressive